Still, PRMT5 inhibitors are increasingly studied in the context of both GB cell lines and primary cells68,69, and some reports also indicate inverse correlation between the PRMT5 expression levels and survival of patients with glioma or GB diagnosis70,71. This evidence concerns the gene PRMT5 and central nervous system cancer.